Qingbin Cui
Impact in
- Oncology top 5%
- Drug Transport and Resistance Mechanisms
- Cancer Research top 10%
Papers in
- Oncology 23
- Drug Transport and Resistance Mechanisms 19
-
- Cancer therapeutics and mechanisms 8
- Co-authors
- Zhe‐Sheng Chen (20 shared papers)Jing‐Quan Wang (16 shared papers)Yehuda G. Assaraf (3 shared papers)Charles R. Ashby (6 shared papers)Dong‐Hua Yang (10 shared papers)Liuya Wei (2 shared papers)Pranav Gupta (5 shared papers)Chao‐Yun Cai (9 shared papers)
- Journals
- Frontiers in Oncology (6 papers)Frontiers in Pharmacology (5 papers)Drug Resistance Updates (3 papers)International Journal of Molecular Sciences (3 papers)Cancer Letters (2 papers)
- Partner nations
- ChinaUnited StatesIsrael
In The Last Decade
Qingbin Cui
43 papers receiving 1.9k citations
Qingbin Cui's Hit Papers
Peers
Comparison fields: 5 of 116
- Oncology 623
- Cancer Research 254
- Molecular Biology 955
- Toxicology 44
- Biomaterials 107
Countries citing papers authored by Qingbin Cui
This map shows the geographic impact of Qingbin Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingbin Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingbin Cui more than expected).
Fields of papers citing papers by Qingbin Cui
This network shows the impact of papers produced by Qingbin Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingbin Cui. The network helps show where Qingbin Cui may publish in the future.
Co-authors
The 25 scholars most cited alongside Qingbin Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Modulating ROS to overcome multidrug resistance in cancer Hit paper breakdown → | 2018 | 563 |
| 2 | 2019 | 264 | |
| 3 | Multidrug resistance proteins (MRPs): Structure, function and the overcoming of cancer multidrug resistance Hit paper breakdown → | 2021 | 174 |
| 4 | 2018 | 96 | |
| 5 | 2017 | 65 | |
| 6 | 2020 | 49 | |
| 7 | 2019 | 45 | |
| 8 | 2020 | 41 | |
| 9 | 2016 | 38 | |
| 10 | 2019 | 35 | |
| 11 | 2019 | 34 | |
| 12 | 2015 | 32 | |
| 13 | 2020 | 32 | |
| 14 | 2020 | 31 | |
| 15 | 2019 | 29 | |
| 16 | 2019 | 28 | |
| 17 | 2020 | 27 | |
| 18 | 2020 | 26 | |
| 19 | 2020 | 26 | |
| 20 | 2014 | 25 |
About Qingbin Cui
Qingbin Cui is a scholar working on Oncology, Molecular Biology, Cancer Research, Infectious Diseases and Surgery, having authored 50 papers that have together received 1.9k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (19 papers), Cancer therapeutics and mechanisms (8 papers), HIV/AIDS drug development and treatment (7 papers), Traditional Chinese Medicine Analysis (4 papers), Hepatitis B Virus Studies (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers), Cancer, Lipids, and Metabolism (3 papers) and Pharmacological Effects of Natural Compounds (3 papers). The work is most often cited by research in Oncology (623 citations), Cancer Research (254 citations), Molecular Biology (955 citations), Toxicology (44 citations) and Biomaterials (107 citations). Qingbin Cui has collaborated with scholars based in China, United States and Israel. Frequent co-authors include Zhe‐Sheng Chen, Jing‐Quan Wang, Yehuda G. Assaraf, Charles R. Ashby, Dong‐Hua Yang, Liuya Wei, Pranav Gupta, Chao‐Yun Cai, Liang Ren and Yuqi Yang. Their work appears in journals such as Frontiers in Oncology, Frontiers in Pharmacology, Drug Resistance Updates, International Journal of Molecular Sciences and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.